FIGS: Growth Is Real, But the Margin Headline Was a One-Time Tariff Refund — Hold After the Rally

FIGS surged 27% on the day after reporting second-quarter results that, at a glance, looked like a margin-breakout story. Revenue grew 28.8% to $196.6 million, beating the consensus estimate of roughly $186 million. Gross margin jumped 820 basis points to 75.2%. Operating margin leaped to 17.9% from 6.5% a year earlier. Management raised its full-year revenue growth guidance to approximately 20%, up from the 14%–16% range, and authorized another $100 million in share repurchases.

The problem: about 780 of those 820 basis points of gross margin expansion came from IEEPA tariff refunds on goods sold in the prior fiscal year. That is a one-time accounting event, not a structural improvement in pricing power or supply chain efficiency. Strip it out, and organic gross margin growth was roughly 40 basis points. The company also excluded $7.9 million in tariff refunds from its adjusted EBITDA calculation. Meanwhile, operating margin benefited from lower stock-based compensation, which is a real cost reduction but one that tends to be volatile rather than permanent.

This is the distinction between a stock that is improving and one that the market has already priced for perfection.

The organic growth story is legitimate

What the tariff refund obscures is that FIGS is genuinely growing faster. Revenue growth of 28.8% marks the third consecutive quarter above 25%. The company has beaten consensus revenue estimates for four straight quarters and surpassed EPS expectations just as long. That kind of consistency in a direct-to-consumer healthcare apparel business matters because it shows the brand is pulling in customers, not just riding a one-time promotional wave.

Underlying metrics support that case. Active customers grew 13% year-over-year to 3.1 million. Average order value hit a record $127, up 8.5%, driven by higher average unit retail prices and a favorable product mix. Non-scrubwear revenue grew 40.3% to $35.4 million, showing the company is expanding beyond its core scrubwear category, which itself grew 26.5%. International revenue surged 67% to $37.9 million — still only about 19% of total revenue, but a growth vector with room to run.

Free cash flow swung from negative $13.5 million in Q2 2025 to positive $44.3 million this quarter. That reversal is the kind of inflection that matters for a company this size: it shows the business can fund its own growth rather than burning capital to chase it.

The valuation question after a 27% jump

At $14.26, where the stock traded in today's session, FIGS carries a forward P/E of 169x. That number alone tells you what the market is asking investors to believe about the next two years of earnings. The trailing P/E is 38x, more palatable but still premium for a specialty apparel company. Enterprise value sits at roughly $2.07 billion with a market cap of $2.37 billion — the balance sheet is clean, with $108.5 million in cash, $140.3 million in total debt, and a current ratio of nearly 5x.

Compare that to Boot Barn, a peer in the specialty retail space, which trades at a trailing P/E of 20x and an EV/EBITDA of roughly 12x. FIGS trades at 24.7x EV/EBITDA, more than double. FIGS is growing faster, but not 170x faster than where its earnings are projected to land next year.

The raised full-year guidance to approximately 20% revenue growth is impressive. On a prior-year revenue base, that implies roughly $700 million in full-year 2026 revenue. The issue is that the 169x forward multiple assumes earnings compound at a rate that leaves almost no room for a quarter where growth slows, tariffs bite, or the promotional mix gets heavier.

What changes the thesis

The next earnings report is the test. Investors need to see whether FIGS can expand margins without a tariff refund tailwind. If gross margin stays near 75% on organic pricing and efficiency alone, the stock earns its higher multiple. If it reverts toward the 67% range that characterized Q2 2025, the current forward valuation becomes indefensible.

International growth is the second proof point. At 67% growth but still a small share of revenue, FIGS has demonstrated it can scale outside the U.S. — but international operations often carry lower margins in the early stages. If that segment expands while maintaining acceptable unit economics, it adds durable revenue growth. If it drags on profitability, it becomes a distraction.

The $200 million cumulative buyback authorization (the company had an existing program and added another $100 million this quarter) is a positive signal at these levels, but the company's net cash position of roughly $108.5 million means buybacks will eat into the liquidity buffer. That's manageable today, but it narrows the margin for error if growth falters.

Rating: Hold

FIGS is a company executing well on a real growth trajectory. Revenue acceleration, pricing power, customer expansion, and the FCF turnaround are not the stuff of a brand riding its past reputation. But the margin headline that drove today's 27% rally was not organic — it was a one-time tariff refund dressed up as operating leverage. At 169x forward earnings, the stock is pricing in flawless quarters ahead.

The growth is real enough to own. The valuation after today's move is not cheap enough to add. Hold current positions and watch the next earnings report for whether margin expansion holds up without the tariff refund. If it does, upgrade to Buy. If it doesn't, the multiple will correct itself.

Next catalyst: Q3 2026 earnings, expected late November 2026. The single question: can gross margin stay elevated on organic drivers alone?